Literature DB >> 2872466

"Inodilators".

L H Opie.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 2872466

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Noninvasive assessment of the inodilator action of amrinone in healthy man.

Authors:  C de Mey; D Enterling; G Hanft
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Treatment of mild congestive heart failure. The potential for new drugs to reduce the risks.

Authors:  U Ravens; M Wehr
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

3.  Acute hemodynamic effects and preload-dependent cardiovascular profile of the partial phosphodiesterase inhibitor nanterinone in patients with mild to moderate heart failure.

Authors:  W J Remme; M van der Ent; G L Bartels; D van Schelven; D C van Hoogenhuyze; X H Krauss; H A Kruijssen; C J Storm
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

Review 4.  Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.

Authors:  Satyan Lakshminrusimha; Bobby Mathew; Corinne L Leach
Journal:  Semin Perinatol       Date:  2016-01-14       Impact factor: 3.300

5.  Acute hemodynamic effects of MDL19205 on conscious dogs with mitral regurgitation.

Authors:  T Susawa; Y Kihara; S Miyazaki; Y Nakamura; S Sasayama; C Kawai
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

6.  Lack of tolerance development during chronic ibopamine administration to patients with congestive heart failure.

Authors:  L Dei Cas; M Metra; S Nodari; S Riva; C Manca; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

Review 7.  Phosphodiesterase III inhibitors: long-term risks and short-term benefits.

Authors:  J M Cruickshank
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

Review 8.  Can new inodilators displace digitalis in the therapy of congestive heart failure?

Authors:  T Kumada; C Kawai
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727

9.  Peripheral hemodynamic effects of ibopamine in patients with congestive heart failure. A placebo-controlled, double-blind study.

Authors:  C Longhini; L Ansani; G F Musacci; S Aggio; E Baracca; T Toselli; P Ghirardi
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

Review 10.  Milrinone in congenital diaphragmatic hernia - a randomized pilot trial: study protocol, review of literature and survey of current practices.

Authors:  Satyan Lakshminrusimha; Martin Keszler; Haresh Kirpalani; Krisa Van Meurs; Patricia Chess; Namasivayam Ambalavanan; Bradley Yoder; Maria V Fraga; Holly Hedrick; Kevin P Lally; Leif Nelin; Michael Cotten; Jonathan Klein; Stephanie Guilford; Ashley Williams; Aasma Chaudhary; Marie Gantz; Jenna Gabrio; Dhuly Chowdhury; Kristin Zaterka-Baxter; Abhik Das; Rosemary D Higgins
Journal:  Matern Health Neonatol Perinatol       Date:  2017-11-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.